П.А. Сломинский

Alieva AKh, Filatova EV, Karabanov AV, Illarioshkin SN, Limborska SA, Shadrina M.I., Slominsky PA. miRNA expression is highly sensitive to a drug therapy in Parkinson's disease. Parkinsonism & Related Disorders 2014, DOI: 10.1016/j.parkreldis.2014.10.018

Alieva AKh, Shadrina MI, Filatova EV, Karabanov AV, Illarioshkin SN, Limborska SA, Slominsky PA. Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease. Biomed Res Int. 2014;2014:718732. doi: 10.1155/2014/718732.

Ripke, S; ...; Khrunin, A; .Slominsky, P.. ; Limborska, S; ...; O'Donovan, MC. Biological insights from 108 schizophrenia-associated genetic loci. Nature, 2014. Volume: 511, Issue: 7510, Pages: 421-427.

T. Kolomin, M. Shadrina, M. Morozova, A. Volkova, L. Andreeva, P. Slominsky, S. Limborska, N. Myasoedov, The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action, Molecular Immunology 2014;58(1):50-5. doi: 10.1016/j.molimm.2013.11.002.

Semenova EV, Shadrina MI, Slominsky PA, Ivanova-Smolenskaya IA, Bagyeva G, Illarioshkin SN, Limborska SA. Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease. Mov Disord. 2012 Jan;27(1):139-42